ArticlePharmaceuticals (Basel, Switzerland)2023

Preclinical Study of ZSP1273, a Potent Antiviral Inhibitor of Cap Binding to the PB2 Subunit of Influenza A Polymerase.

Xiaoxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.